Identity Solutions Provider BIO-key Honored with Cybersecurity Excellence Awards in Four Categories

WALL, N.J., Feb. 09, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, announced today that its solutions have been honored as Gold badge winners in four product categories for the 2022 Cybersecurity Excellence Awards. BIO-key’s PortalGuard Identity-as-a-Service (IDaaS) platform was awarded the Gold badge in the Identity and Access Management, Multi-factor Authentication, and Single Sign-On product categories, while the company’s Identity-Bound Biometrics were awarded the Gold badge in the Biometrics category.

The Cybersecurity Excellence Awards are a worldwide program produced by Cybersecurity Insiders and the Information Security Community on LinkedIn to recognize and honor the world’s most innovative cybersecurity organizations, products, and professionals. Nominations are reviewed by cybersecurity experts at both organizations, with voting taking place on the Cyber Security Excellence Awards website.

“It’s an honor to be recognized by this group of cybersecurity experts,” said Michael DePasquale, BIO-key Chairman and CEO. “Winning in these product categories recognizes the hard work and innovation that we’ve put into our solutions to continue to lead the market by providing a unique combination of IAM and Identity-Bound Biometrics for our customers.”

For over 25 years, organizations across all verticals, especially in higher education, finance, government, and healthcare have trusted BIO-key to help them eliminate passwords, secure remote access, prevent cyberattacks, and improve productivity for their IT teams. BIO-key's award-winning solutions offer an easy and secure way to authenticate the identity of employees, customers, and suppliers, while managing their access across devices and applications.

To learn more about BIO-key’s solutions please visit the company website.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key’s patented software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, risks and uncertainties including our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Media Contacts
Tim Hurley, Erin Knapp Matter Communications
[email protected]
617-201-9152

Investor Contacts
William Jones, David Collins Catalyst IR
[email protected]
212-924-9800